FindTrial
Sign In

Effect of subcutanous injection of nitroglycerine on radial artery cannulation

Comparative study of periarterial Infilteration of nitroglycerine with lignocaine vs lignocaine alone in ultrasound guided radial artery cannulation in ICU patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044209
Enrollment
60
Registered
2022-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: - Health Condition 4: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: Radial artery cannulation: Subcutanous infiltration of lignocaine-nitroglycerine mixture result in significant increase in radial artery diameter in LN group in comparison to L GROUP Co

Sponsors

Department of Anaesthesiology and Critical care Pt BD Sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All ICU patients in age group 18-65 years who require radial artery cannulation for IBP monitoring and frequent ABG analysis

Exclusion criteria

Exclusion criteria: Modified allen test coagulopathy (INR >1.5), Platelet count <70000,peripheral artery disease ,hand deformity ,inadequate circulation to upper extremity infection over injection site .

Design outcomes

Primary

MeasureTime frame
To compare radial artery diameter in lignocaine +Nitroglycerine with lignicaine alone.Timepoint: Radial artery diameter 3minutes after subcutanous infilteration of drugs—

Secondary

MeasureTime frame
To compare change in radial artery diameter in both groupTimepoint: 3 minutes after subcutanous infilteration of study drug—

Countries

India

Contacts

Public ContactGeeta Ahlawat

PGIMS ROHTAK

drgeetasaroha@gmail.com9215810279

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026